O'Shaughnessy Michelle M, Hogan Susan L, Poulton Caroline J, Falk Ronald J, Singh Harsharan K, Nickeleit Volker, Jennette J Charles
Division of Nephropathology, Department of Pathology and Laboratory Medicine, and.
Division of Nephrology, Department of Medicine and the Kidney Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina; and.
Clin J Am Soc Nephrol. 2017 Apr 3;12(4):614-623. doi: 10.2215/CJN.10871016. Epub 2017 Mar 21.
Large-scale, contemporary studies exploring glomerular disease epidemiology in the United States are lacking. We aimed to determine 30-year temporal and demographic trends in renal biopsy glomerular disease diagnosis frequencies in the southeastern United States.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this cross-sectional, observational study, we identified all patients with a native kidney biopsy specimen showing one of 18 widely recognized glomerular disease diagnoses referred to the University of North Carolina Chapel Hill Division of Nephropathology between 1986 and 2015. Biopsy era (1986-1995, 1996-2005, and 2006-2015) and demographics (age, sex, and race) were our primary and secondary predictors, respectively, and the relative frequency of each glomerular disease diagnosis was our primary outcome.
Among 21,374 patients (mean age =48.3±18.3 years old; 50.8% men; 56.8% white; 38.3% black; 2.8% Latino; 1.4% Asian; 0.8% other), the frequency of diabetic glomerulosclerosis in renal biopsy specimens increased dramatically over the three decades (5.5%, 11.4%, and 19.1% of diagnoses, respectively; for trend <0.001). The frequency of FSGS initially increased but then declined (22.6%, 27.2%, and 24.7%, respectively; for trend =0.64). The frequencies of other common glomerular disease subtypes remained stable (IgA nephropathy and ANCA/pauci-immune GN) or declined (minimal change disease, membranous nephropathy, membranoproliferative GN, and lupus nephritis). These temporal trends were largely preserved within all demographic subgroups, although cross-sectional frequency distributions differed according to age, sex, and race.
We identified significant changes in relative renal biopsy frequencies of many glomerular disease subtypes over three decades. Temporal trends were consistently observed within all major demographic groups, although relative predominance of individual glomerular disease subtypes differed according to patient age, sex, and race. We propose that exploration of behavioral and environmental exposures that likely underlie these findings should be the focus of future hypothesis-driven research.
目前缺乏对美国肾小球疾病流行病学的大规模当代研究。我们旨在确定美国东南部肾活检肾小球疾病诊断频率的30年时间和人口统计学趋势。
设计、背景、研究对象与测量指标:在这项横断面观察性研究中,我们确定了1986年至2015年间转诊至北卡罗来纳大学教堂山分校肾病病理学部门的所有肾活检标本显示18种广泛认可的肾小球疾病诊断之一的患者。活检年代(1986 - 1995年、1996 - 2005年和2006 - 2015年)和人口统计学特征(年龄、性别和种族)分别为我们的主要和次要预测因素,每种肾小球疾病诊断的相对频率为我们的主要结局指标。
在21374例患者中(平均年龄 = 48.3±18.3岁;男性占50.8%;白人占56.8%;黑人占38.3%;拉丁裔占2.8%;亚洲人占1.4%;其他占0.8%),肾活检标本中糖尿病肾小球硬化症的频率在这三十年中显著增加(分别占诊断的5.5%、11.4%和19.1%;趋势P<0.001)。局灶节段性肾小球硬化症的频率最初增加但随后下降(分别为22.6%、27.2%和24.7%;趋势P = 0.64)。其他常见肾小球疾病亚型的频率保持稳定(IgA肾病和抗中性粒细胞胞浆抗体/寡免疫性肾小球肾炎)或下降(微小病变病、膜性肾病、膜增生性肾小球肾炎和狼疮性肾炎)。尽管横断面频率分布因年龄、性别和种族而异,但这些时间趋势在所有人口统计学亚组中基本保持一致。
我们发现三十年来许多肾小球疾病亚型的相对肾活检频率有显著变化。尽管各肾小球疾病亚型的相对优势因患者年龄、性别和种族而异,但在所有主要人口群体中均一致观察到时间趋势。我们建议,探索可能是这些发现基础的行为和环境暴露因素应成为未来假设驱动研究的重点。